Halozyme Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, HALO, Halozyme Therapeutics Inc, priceseries

Halozyme Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
35.09
Close
34.75
High
35.49
Low
34.58
Previous Close
35.11
Daily Price Gain
-0.36
YTD High
42.33
YTD High Date
Jan 4, 2022
YTD Low
31.36
YTD Low Date
Jan 28, 2022
YTD Price Change
-6.31
YTD Gain
-15.37%
52 Week High
51.57
52 Week High Date
Apr 29, 2021
52 Week Low
31.36
52 Week Low Date
Jan 28, 2022
52 Week Price Change
-4.76
52 Week Gain
-12.05%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 4. 2017
10.69
Jan 11. 2017
12.07
5 Trading Days
12.92%
Link
LONG
Jun 16. 2017
13.44
Jun 27. 2017
14.17
7 Trading Days
5.42%
Link
LONG
Sep 13. 2017
13.18
Oct 6. 2017
17.17
17 Trading Days
30.31%
Link
LONG
Jan 4. 2019
14.72
Jan 23. 2019
15.83
12 Trading Days
7.55%
Link
LONG
Nov 12. 2019
16.77
Dec 2. 2019
18.78
13 Trading Days
12.00%
Link
LONG
Apr 16. 2020
18.59
May 12. 2020
22.50
18 Trading Days
21.04%
Link
LONG
Jun 29. 2020
25.82
Jul 13. 2020
27.39
9 Trading Days
6.07%
Link
LONG
Oct 7. 2020
27.56
Oct 27. 2020
29.94
14 Trading Days
8.65%
Link
LONG
Nov 3. 2020
31.62
Nov 30. 2020
38.78
18 Trading Days
22.63%
Link
LONG
Jan 13. 2021
45.13
Jan 27. 2021
47.46
9 Trading Days
5.17%
Link
LONG
Apr 9. 2021
42.77
May 3. 2021
49.59
16 Trading Days
15.94%
Link
Company Information
Stock Symbol
HALO
Exchange
NasdaqGS
Company URL
http://http://www.halozyme.com
Company Phone
(858) 794-8889
CEO
N/A
Headquarters
California
Business Address
11388 SORRENTO VALLEY ROAD, SAN DIEGO, CA 92121-1345
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001159036
About

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other d...

Description

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes and other drug candidates in the United States, Switzerland, and internationally. The company's human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter tissue structures for clinical benefit. Its products are based on the Enhanze technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. The company offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration; to enhance the dispersion and absorption of other injected drugs; in subcutaneous urography; and to enhance resorption of radiopaque agents. It also develops PEGylated recombinant human hyaluronidase for the treatment of pancreatic ductal adenocarcinoma, non-small cell lung cancer, gastric cancer, and metastatic breast cancer. It has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; and Genentech. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading